drugset / Trial / NCT00946179
Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study is in support of the annual application for the variation of the vaccine strains for a marketing authorization. Objectives: * To evaluate the compliance, in terms of immunogenicity, of the influenza vaccine (split virion, inactivated) Northern Hemisphere (NH) 2009-2010 formulation in two adult groups, aged 18 to 60 years and aged 61 years or older. * To describe the safety of the influenza vaccine (split virion, inactivated) NH 2009-2010 formulation in both adult groups.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza virus (split virion, inactivated) vaccine | Vaccine | 0.5 ml | Intramuscular |